Fulgent Genetics, Inc. (FLGT) Social Stream



Fulgent Genetics, Inc. (FLGT): $57.61

2.12 (+3.82%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Fulgent Genetics Inc (FLGT) Price Targets From Analysts

Use the tables below to see what analysts covering Fulgent Genetics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-09-28 1 $141 $141 $141 $62.41 125.93%
2022-01-24 1 $125 $125 $125 $62.41 100.29%
2022-02-04 2 $125 $80 $102.5 $62.41 64.24%
2022-02-24 2 $123 $80 $101.5 $62.41 62.63%
2022-02-28 2 $123 $85 $104 $62.41 66.64%

The Trend in the Analyst Price Target


FLGT's average price target has moved up $87.67 over the prior 21 months.

FLGT reports an average of 52.48% for its upside potential over the past 40 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-27 4 140 35 87.0 76.89 13.15%
2021-09-19 4 141 65 103.0 91.71 12.31%
2021-09-20 4 141 65 103.0 88.87 15.9%
2022-02-24 2 123 80 101.5 61.43 65.23%
2022-02-28 2 123 85 104.0 62.30 66.93%

FLGT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


FLGT's average broker recommendation rating improved by 0.67 over the prior 18 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for FLGT as an investment opportunity.

  • In the context of all US stocks, Fulgent Genetics Inc's number of analysts covering the stock is greater than 23.45% of them.
  • Fulgent Genetics Inc's average analyst price target is greater than 616.24% of stocks in the mid market cap category.
  • In the context of Healthcare stocks, Fulgent Genetics Inc's variance in analysts' estimates is lower than -28.41% of them.
  • In terms of how Fulgent Genetics Inc fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 533.16% of that group.

In the Healthcare industry, ENZ, CDNA, and BNR are the three stocks most similar to Fulgent Genetics Inc regarding the price target and analyst recommendation information presented here.

Is FLGT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6867 seconds.